¹û¶³Ó°Ôº

XClose

¹û¶³Ó°Ôº Division of Medicine

Home
Menu

Metabolism and Inflammation

The Centre of Metabolism and Inflammation aims to investigate diagnostics and therapeutics for Non-Communicable Diseases. We want to improve the health of low/middle-income communities by investigating the burden of non-communicable diseases (NCDs).

Our mission 

  • Contribute to the health of low / middle-income communities by investigating the burden of non-communicable diseases (NCDs) on them using an omics approach.
  • Focusing on the inflammatory processes linking NCDs, both as cause and consequence, to metabolic dysfunction.
  • Tailoring diagnostics and therapeutics based on these findings using camelid antibodies.

Our research

Epidemiology and Omics

We have established a detailed phenotypic database, with DNA and serum samples, of a population of low/middle-income subjects: 25,000 (20,000 males completed) and 5,000 females (ongoing), awaiting whole genome sequencing and metabolomics.

Molecular mechanisms

We are undertaking detailed physiological studies to understand the specific molecular mechanisms that may underlie the abnormalities within these populations, specifically addressing resistance to the actions of insulin. As we accumulate greater volumes of data from these cohorts, we aim to develop more representative norms than those currently used for reference.

Therapeutics/Diagnostics - Generation of VHH Fragments from Immunized Camels

We have established a platform for producing camel VHH fragment antibodies to various neuro-immunomodulatory targets. In addition, unique and novel targets from results obtained in the multi-omics studies in the low/middle-income communities are also being investigated. 


Research at the Centre of Metabolism & Inflammation: 1st Annual Symposium

The first annual symposium for research at the Centre of Metabolism & Inflammation took place on 12 September 2024 at the Royal College of Physicians.

The keynote address was made by Prof. Dame Carol Black DBE. Other contributions came from members of CoMI, the ¹û¶³Ó°Ôº Institute of Cardiovascular Science and ADLQ.

Download Programme (PDF)

The ¹û¶³Ó°Ôº Portico Building

Our experts

Mohammed Al-Maadheed portrait

Prof. Mohammed Al-Maadheed

Vidya Mohamed-Ali portrait

Chidambaram Manickam

Dr Chidambaram Manickam

Konduru Seetharama Sastry portrait

Dr Konduru Seetharama Sastry

Basic silhouette in a circle, in light grey

Dr Maneera Al-Jabr

Basic silhouette in a circle, in light grey

Dr Mark Stuart


PhD students

Fatima Al-Hatimy

Investigation of the strategic decision-making process and assessment of its impact on Qatar’s healthcare system

Previous work recommended the use of rational decision-making, through strategic planning in order to improve the healthcare system in Qatar, specifying planning as a governance issue, and advocating a need for planning controls and monitoring capacity. This project is conducting a thorough quantitative assessment, using NCDs as a case study of the impact of changes within Qatar’s healthcare system, and benchmarks it against countries of similar size and government, such as Singapore.

Nada Mohamed-Ali

Investigation of Camel-derived Antibodies & VHH Fragments in Inflammatory Fibrotic Disease  

The association between chronic, sub-clinical inflammation and several metabolic diseases is well established. Interleukin-6 (IL-6) has been shown to be an important regulator of fibrosis in insulin-responsive organs, such as the liver, adipose tissue, skeletal muscle and the heart. The cytokine appears to mediate the process leading to permanent scaring that fails to return the tissue to normal function.  The therapeutic potential of IL-6 suppression in diabetes-associated tissue fibrosis is an area of intense research activity.

Dr Maryam AlNesf Al Mansouri

Noor Al-Naimi

Ijeoma Ibeawuchi

Master's students

Ibrahim Al-Mohannadi

Interns

Fatima Al-Musleh (Summer 2024)

Selected publications

  1. Elmadhoun S, Mansi M, Kamal R, Al-Kuwari K, Mohamed-Ali V, Al-Maadheed MÌý(2024). Exploring the Relationship Between Injury, Addiction, and Physical Activity: A Path to Recovery for Athletes. Annals of Clinical and Medical Case Reports. (Accepted.)
  2. Stuart M, Farooq M, Thomas T, Mohamed-Ali N, Al-Maadheed M, Mohamed-Ali V (2024). . Sports Med Open. 2024 Jul 19;10(1): 80.
  3. Siew K, Nestler KA, Nelson C, D'Ambrosio V ... Al-Maadheed M, et al (2024). . Nat Commun. 2024 Jun 11;15(1): 4923.
  4. Chamari K, Kamal R, Mohamed-Ali V, Al-Maadheed M (2024). . New Asian Journal of Medicine, 2(1), 27-31.
  5. Mazzarino M, Al-Mohammed H ... Mohamed-Ali V, Al-Maadheed M (2024). . J Pharm Biomed Anal. 2024 May 15;242: 116007.
  6. Aboujassoum HM, Mohamed-Ali V, et al (2023). . Nutrients. 2023 Dec;16(1): 115.
  7. Schmidt F, Abdesselem HB ... Mohamed-Ali V, Al-Maadheed M, et al (2023). . Front Physiol. 2023 Jul 14;14: 1203723.
  8. El-Agnaf O, Bensmail I ... Al-Maadheed M, Mohamed-Ali V, et al (2023). . Neurobiol Dis. 2023 Jun 15;182: 106147.
  9. Bettahi I, Krishnankutty R … Mohamed-Ali V, et al (2023). . Front Endocrinol (Lausanne). 2023 Feb 17;13: 1024832.
  10. Voss SC, Yassin M, Grivel JC ... Mohamed Ali V, Georgakopoulos C, Al Maadheed M (2022). . Drug Test Anal. 2022 Nov;14(11-12): 1984-1994.
  1. Yu F, Courjaret R, Elmi A, Adap EA ... Mohamed-Ali V, Machaca K (2022). . J Physiol. 2022 Nov;600(22): 4827-4848.
  2. Shen L, Dashwood MR, Casale C ... Mohamed-Ali V (2022). . Life Sci. 2022 Sep 15;305: 120756.
  3. Aljaber MY, Orie NN, Raees A, Kraiem S, Al-Jaber MÌý...ÌýMohamed-Ali V, Almaadheed M (2022). . Future Sci OA. 2022 Jul 7;8(6):FSO805.
  4. Ullah E, El-Menyar A, Kunji K ... Al-Maadheed M, Mohamed-Ali V, et al (2022). . Metabolites. 2022 Jun 3;12(6): 517.
  5. AlJaber M, Abushreeda W, Raees A ... Mohamed-Ali V, Al Maadheed M, Lund G (2022). . Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, Vol. 44(1): 35212-35219, May.
  6. Al-Nesf A, Mohamed-Ali N, Acquaah V, Al-Jaber M ... Mohamed-Ali V, Al-Maadheed M (2022). . Metabolites. 2022 May 10;12(5): 425.
  7. Al-Nesf MAY, Abdesselem HB, Bensmail I ... Al-Maadheed MÌý... Mohamed-Ali V, Al-Ejeh F (2022). . Nat Commun. 2022 Feb 17;13(1): 946.
  8. Al-Hatimy F, Farooq A, Al Abiad M, Yerramsetti S ... Mohamed-Ali V, Al-Maadheed M (2022). . Int J Environ Res Public Health. 2022 Feb 17;19(4): 2266.
  9. Orie NN, Raees A, Aljaber MY, Mohamed-Ali N  … Mohamed-Ali V, Almaadheed M (2021).Ìý. Phytomedicine Plus, Vol. 1(3).
  10. Ventura R, Daley-Yates P, Mazzoni I ... Stuart M (2021). . Br J Sports Med. 2021 Apr 20.

Funding and partnerships 

Prof. Vidya Mohamed-Ali is a Scientific Advisor to the Anti-Doping Lab Qatar and a member of the Medical & Scientific Committee of the International Olympic Committee. She has contributed to over 100 conference proceedings and media output for the wider public (such as the British Nutrition Foundation Task Force publications) and attracted funding for several student stipends. She has obtained grant funding of £1.95 million and published over 90 peer-reviewed papers, four reviews and contributed chapters to three books. Her work has been cited over 6,000 times, with an H-index of 52.

Anti Doping Lab Qatar logo

Naufa Wellness Recovery Center logo

Qatar Red Crescent Society Logo

Qatar Foundation logo

Related programmes

Contact Details

Email

m.maadheed@ucl.ac.uk

Telephone

+44 (0)20 8016 8347

Postal Address

¹û¶³Ó°Ôº Division of Medicine
Royal Free Hospital Campus
Rowland Hill Street
Hampstead
London
NW3 2PF

Metabolism and Inflammation Group picture